Investigation of Thromboembolic Events in COVID-19 Infected Patients

Authors : Serpil ŞAHİN, Hatice Betül ALTINIŞIK, Sevil ALKAN ÇEVİKER, Uğur KÜÇÜK, Havva Yasemin ÇİNPOLAT, Uğur GÖNLÜGÜR

Pages : 56-60

Doi:10.54005/geneltip.1209433

View : 49 | Download : 9

Publication Date : 2023-02-28

Article Type : Research Paper

Abstract :Aim: In this study, we sought to determine patient characteristics and clinical outcomes of patients who experience this complication, as well as the frequency of thromboembolic events insert ignore into journalissuearticles values(TEE); in COVID-19 patients hospitalized. Materials and Methods: Between January 2020 and December 2021, all the patients with positive COVID-19 PCR test results were enrolled in this study. The data of the cases that developed TEE with the diagnosis of COVID-19 were evaluated retrospectively. Results:During this time, 2,845 inpatients were admitted with COVID-19. Among this group, 96 patients insert ignore into journalissuearticles values(3.37%); had COVID-19 - related TEE. The mean age was 63.76±13.85 years insert ignore into journalissuearticles values(range, 28–80 years); with 46 men insert ignore into journalissuearticles values(47.92%); and 50 women insert ignore into journalissuearticles values(52.08%);. Of the patients, 46 of 96 insert ignore into journalissuearticles values(47.92%); had severe COVID-19, and 50 of 96 insert ignore into journalissuearticles values(52.08%); had only mild respiratory symptoms. Severe COVID-19 group patients were older but there was not statistically significance between the groups. Peripheral venous disease was more common in mild COVID-19 group, while peripheral arterial disease is more common in severe COVID-19 group.CRP, uric acid, troponin, creatinine,D-dimer and leukocyte levels were higher in severe COVID-19 patients with TEE insert ignore into journalissuearticles values(p<0.05);. Peripheral venous disease was present in 81 of 96 insert ignore into journalissuearticles values(84.37%);, peripheral arterial disease in 5 of 96 insert ignore into journalissuearticles values(5.2%);, and pulmonary embolism in 11 insert ignore into journalissuearticles values(11.45%); cases. One patient insert ignore into journalissuearticles values(1.04%); had both peripheral venous disease and pulmonary embolism. The overall mortality was 6.25% insert ignore into journalissuearticles values(6/96);. Conclusion: COVID-19-associated thrombotic process affects more frequently veins than arteries. Given the significant observed risk for TEE in COVID-19, diagnostic imaging for TEE should be evaluated with a high degree of clinical suspicion.
Keywords : COVID 19, SARS CoV 2, Thrombosis, Embolism

ORIGINAL ARTICLE URL